CC BY-NC-ND 4.0 · AJP Rep 2019; 09(04): e366-e371
DOI: 10.1055/s-0039-1695746
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pyelonephritis in Pregnancy: Relationship of Fever and Maternal Morbidity

Tracey H. DeYoung
1   Department of Obstetrics and Gynecology, Naval Medical Center Portsmouth, Portsmouth, Virginia
,
2   Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
,
Christopher S. Ennen
1   Department of Obstetrics and Gynecology, Naval Medical Center Portsmouth, Portsmouth, Virginia
,
Aaron T. Poole
1   Department of Obstetrics and Gynecology, Naval Medical Center Portsmouth, Portsmouth, Virginia
› Author Affiliations
Further Information

Publication History

27 February 2019

09 July 2019

Publication Date:
19 November 2019 (online)

Abstract

Objective To evaluate the relationship between maternal fever at the time of hospital admission and subsequent maternal morbidity in pregnant patients with pyelonephritis.

Study Design In this retrospective cohort study, inpatient records were reviewed for all obstetric patients discharged from a single tertiary care hospital between June 1, 2011, and May 30, 2017, with the diagnosis of pyelonephritis. Patients were stratified into two groups, those with and without fever at the time of admission. Descriptive statistics were utilized to evaluate the association of fever at the time of presentation with subsequent morbidity. Using admission vital signs, maternal early warning criteria (MEWC) were applied and odds ratios calculated to predict intensive care unit (ICU) admission.

Results A total of 110 patients were admitted with pyelonephritis in pregnancy; 24 patients were febrile and 86 patients were afebrile on admission. There was no difference in rates of maternal ICU admission between both groups. Positive MEWC was predictive of ICU admission with an adjusted odds ratio of 16.54 (95% confidence interval: 1.29–212.5; p = 0.03).

Conclusion Afebrile pregnant patients with pyelonephritis remain at risk of significant maternal morbidity. Application of the MEWC on admission identifies patients at higher risk of ICU admission.

Note

I am a military service member. This work was prepared as part of my official duties. Title 17 U.S.C. 105 provides that “Copyright protection under this title is not available for any work of the United States government.” Title 17 U.S.C. 101 defines a United States government work as a work prepared by a military service member or employee of the United States government as part of that person's official duties.


The study protocol was approved by the Naval Medical Center Portsmouth Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects.


Research data derived from an approved Naval Medical Center, Portsmouth, Virginia IRB, protocol; number NMCP.2017.0061.


 
  • References

  • 1 Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014; 210 (03) 219.e1-219.e6
  • 2 Say L, Chou D, Gemmill A. , et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2 (06) e323-e333
  • 3 Hill JB, Sheffield JS, McIntire DD, Wendel Jr GD. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005; 105 (01) 18-23
  • 4 Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A): 5S-13S
  • 5 Glaser AP, Schaeffer AJ. Urinary tract infection and bacteriuria in pregnancy. Urol Clin North Am 2015; 42 (04) 547-560
  • 6 Gilstrap III LC, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am 2001; 28 (03) 581-591
  • 7 Le Gouez A, Benachi A, Mercier FJ. Fever and pregnancy. Anaesth Crit Care Pain Med 2016; 35 (Suppl. 01) S5-S12
  • 8 Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol 2012; 120 (03) 689-706
  • 9 Mhyre JM, DʼOria R, Hameed AB. , et al. The maternal early warning criteria: a proposal from the national partnership for maternal safety. Obstet Gynecol 2014; 124 (04) 782-786
  • 10 Gilstrap III LC, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 1981; 57 (04) 409-413
  • 11 Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997; 15 (02) 148-151
  • 12 Friedman AM. Maternal early warning systems. Obstet Gynecol Clin North Am 2015; 42 (02) 289-298
  • 13 Lappen JR, Keene M, Lore M, Grobman WA, Gossett DR. Existing models fail to predict sepsis in an obstetric population with intrauterine infection. Am J Obstet Gynecol 2010; 203 (06) 573.e1-573.e5
  • 14 Chebbo A, Tan S, Kassis C, Tamura L, Carlson RW. Maternal sepsis and septic shock. Crit Care Clin 2016; 32 (01) 119-135
  • 15 Valent AM, Peticca K, DiMatteo A. , et al. Pyelonephritis in pregnancy: prediction of prolonged hospitalization and maternal morbidity using prognostic scoring systems. Am J Perinatol 2017; 34 (12) 1212-1218
  • 16 Wing DA, Park AS, Debuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol 2000; 182 (06) 1437-1440